Skip to main content
Published locations for Cisplatin-gemcitabine is highly active in BRCA/PALB2+ pancreatic cancer
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Cisplatin-gemcitabine is highly active in BRCA/PALB2+ pancreatic cancer
User login
Username
Password
Reset your password
/content/cisplatin-gemcitabine-highly-active-brca/palb2-pancreatic-cancer
/oncologypractice/article/216203/gastroenterology/cisplatin-gemcitabine-highly-active-brca/palb2
/hematology-oncology/article/216203/gastroenterology/cisplatin-gemcitabine-highly-active-brca/palb2